Agios Pharmaceuticals Inc (AGIO)
32.05
+0.38
(+1.20%)
USD |
NASDAQ |
Apr 25, 14:47
Agios Pharmaceuticals Profit Margin (Quarterly): -1.35K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.35K% |
| September 30, 2023 | -1.23K% |
| June 30, 2023 | -1.25K% |
| March 31, 2023 | -1.44K% |
| December 31, 2022 | |
| September 30, 2022 | -2.32K% |
| June 30, 2022 | -1.64K% |
| March 31, 2022 | -11.39K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -408.0% |
| June 30, 2019 | -419.0% |
| March 31, 2019 | -307.9% |
| December 31, 2018 | -305.8% |
| September 30, 2018 | -622.9% |
| June 30, 2018 | -170.1% |
| March 31, 2018 | -1.04K% |
| Date | Value |
|---|---|
| December 31, 2017 | -901.0% |
| September 30, 2017 | -679.1% |
| June 30, 2017 | -732.3% |
| March 31, 2017 | -629.7% |
| December 31, 2016 | -249.4% |
| September 30, 2016 | -699.3% |
| June 30, 2016 | -801.8% |
| March 31, 2016 | -74.16% |
| December 31, 2015 | -653.3% |
| September 30, 2015 | -734.6% |
| June 30, 2015 | -241.3% |
| March 31, 2015 | -14.49% |
| December 31, 2014 | -182.2% |
| September 30, 2014 | 10.93% |
| June 30, 2014 | -217.5% |
| March 31, 2014 | -145.6% |
| December 31, 2013 | -183.6% |
| September 30, 2013 | -178.3% |
| June 30, 2013 | -137.5% |
| March 31, 2013 | -115.3% |
| December 31, 2012 | -84.58% |
| September 30, 2012 | -74.11% |
| June 30, 2012 | -87.67% |
| March 31, 2012 | -73.88% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.39K%
Minimum
Mar 2022
-408.0%
Maximum
Sep 2019
-2.39K%
Average
-1.35K%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -31.35% |
| Blueprint Medicines Corp | -154.1% |
| Corcept Therapeutics Inc | 23.16% |
| Ionis Pharmaceuticals Inc | -2.85% |
| Madrigal Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.68% |
| Return on Assets | -32.48% |
| Return on Invested Capital | -36.68% |
| Gross Profit Margin (Quarterly) | 91.75% |
| Operating Margin (Quarterly) | -1.50K% |
| Return on Net Operating Assets | -368.7% |